Table 2 Pathological results and location of metastasis after three operations
Hospital | Time | Clinical symptoms | Pathology | Immunohistochemistry | Indicator of progressive increase | Tumor metastasis |
|---|---|---|---|---|---|---|
Local hospital | 2015 | A painless mass | Sweat gland carcinoma | CK5/6(+), CK-20(−), CEA(−), BCL-2(+, 2%), KI-67(2 + , 60%), EMA(++) | KI-67(+, 60%) | No metastasis |
First Affiliated Hospital of Medical College of Zhejiang University | 2017 | A painless mass | malignant eccrine carcinoma | CK5/6(+), CK7(+), CK20(+), P63(−), MMG(−), S-100(−), Ki-67(+, 70%),G15(−), CD43(−), PAS(+) | Ki-67(+, 70%) | Local skull metastasis |
First Affiliated Hospital of Medical College of Zhejiang University | 2018 | Mass with tenderness Headache Intracranial hypertension | malignant eccrine carcinoma | CK5/6(+), CK7(+), CK20(−), P63(−), MMG(−), S-100(−), Ki-67(+, > 60%),G15(−), CD43(−), GCDFP15(−) | Ki-67(++, > 60%) | Local skull metastasis Dura metastasis |